Study of Cetrorelix in Inhibition of Side Effect of Vinblastin Used in Chemotherapy on Germinal Epithelium in Mouse Testis

Study of Cetrorelix in Inhibition of Side Effect of Vinblastin Used in Chemotherapy on Germinal Epithelium in Mouse Testis


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: داریوش محمدنژاد , لیلا روشنگر , ابراهیم اختری شجاعی

کلمات کلیدی: Anticancer drug, GnRH antagonist, Chemotherapy, Cetrorelix

نشریه: 15867 , 5 , 0 , 2011

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله ابراهیم اختری شجاعی
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه مرکز تحقیقات سل و بیماری های ریوی
کد مقاله 70653
عنوان فارسی مقاله Study of Cetrorelix in Inhibition of Side Effect of Vinblastin Used in Chemotherapy on Germinal Epithelium in Mouse Testis
عنوان لاتین مقاله Study of Cetrorelix in Inhibition of Side Effect of Vinblastin Used in Chemotherapy on Germinal Epithelium in Mouse Testis
ناشر 7
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ خیر
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

Article abstract: Background: Infertility problem affects young couples. One of the known causes of spermatogenic disorder is chemotherapy in patients with cancer. Since dividing cells are mainly affected by anticancer drugs, the aim of the present study is to investigate the preventive effect of GnRH on spermatogenic defect produced by anticancer drug. Materials and Methods: In the present study 30 adult female mice aging 6-8 weeks were used. The mice were divided into 3 equal groups as control, exp group 1 and exp group 2. In exp group 1vinblastin was injected as ip for 5 days at 0. 25 mg/kg. In exp group 2 group cetrorelix injection was started one week before vinblastin treatment and continued for 3 more weeks. The mice in all groups were sacrificed 3 weeks after the last dose of Cetrorelix injection. Testicular specimens were prepared for LM studies. Results: Microscopic study revealed that in the control group the mean number of sertoli and spermatogonium, were 8.20 ± 1.30 and 56 ± 7.35 respectively. In exp group 1 the mean numbers of above mentioned cells were 18.60 ± 3.65 and 39.80 ± 3.70. In exp group 2 the mean numbers of above mentioned cells were 9.20 ± 1.3 and 54.80 ± 4.95. The data showed the difference between control and exp 1group was significant, but the difference between control and exp 2 was not. Spermatogenesis index (SI) and diameter of germinal epithelium in control group were 0.70 ± 0.30 and 168.80 ± 14.13 respectively. In exp group 1 were 0.17 ± 0.16 and 117.80 ± 14.18 but in exp group 2 were 0.62 ± 0.25 and 161.20 ± 12.21. The data showed the difference between control and exp 1group was significant, but the difference between control and exp 2 was not. Conclusion: It is concluded that GnRH antagonist administration before cancer treatment could prevent the side effect of anticancer drugs.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
داریوش محمدنژاداول
لیلا روشنگرپنجم
ابراهیم اختری شجاعیششم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
Untitled.png1398/10/16142124دانلود